12 January 2011

Invetech to present at Phacilitate's 7th annual Cell & Gene Therapy Forum

David James, Invetech's Director Manufacturing Innovation, will present at the Phacilitate Cell & Gene Therapy Forum, to be held later this month in Washington, DC.

David, in conjunction with key industry leaders, will conduct a Breakfast workshop outlining Cell Therapy commercialisation and the roadmap for success. Speakers will share their first-hand experiences solving the unique challenges that cell therapy companies face as they progress from clinical trials into commercial production.

Speakers include:

  • David A. James, Senior Director - Manufacturing Innovation, Invetech Pty Ltd
  • Morrie Ruffin, Managing Partner Adjuvant Global Advisors, LLC & Director Alliance for Regenerative Medicine
  • Brian Hampson, Senior Engineering Fellow, Aastrom Biosciences
  • Chad Green, Senior Scientist ViaCyte Inc

Breakfast Workshop
Tuesday 25 January 2011 at 7:45am

Phacilitate Cell & Gene Therapy Forum
24-26 January 2010
The Grand Hyatt
Washington DC

Further Press Information

Roger Langsdon, Phone: +613 9211 7782, Fax: +613 9211 7703. E-mail media@invetech.com.au.

Bookmark and Share